Resistance of herpes simplex virus type 1 to peptidomimetic ribonucleotide reductase inhibitors: Selection and characterization of mutant isolates

Journal of Virology

Volumn 70, Issue 2, 1996, Pages 787-793

  Bonneau, Anne Marie ^a   Kibler, Philip ^a   White, Peter ^a   Bousquet, Christiane ^a   Dansereau, Nathalie ^a   Cordingley, Michael G ^a  

^a BOEHRINGER INGELHEIM CANADA LTD   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; BILD 733; BW 348U87; DNA POLYMERASE; RIBONUCLEOTIDE REDUCTASE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; DISSOCIATION CONSTANT; DNA REPLICATION; ENZYME ACTIVITY; HERPES SIMPLEX VIRUS 1; NONHUMAN; PRIORITY JOURNAL; VIRUS MUTANT;

EID: 0030048221     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.2.787-793.1996     Document Type: Article

References (36)

1. Averett, D. R., C. Lubbers, G. B. Elion, and T. Spector. 1983. Ribonucleotide reductase induced by herpes simplex type 1 virus - characterization of a distinct enzyme. J. Biol. Chem 258:9831-9338
2. Brandt, C. R., R. L. Kintner, A. M. Pulmfrey, R. J. Visalli, and D. R. Grau. 1991. The herpes simplex virus ribonucleotide reductase is required for ocular virulence. J. Gen. Virol. 72:2043-2049.
3. Brazeau, P., N. Ling, P. Bohlen, F. Esch, S.-Y. Ying, and R. Guillemin. 1982. Growth hormone releasing factor, somatocrinin, releases pituitary growth hormone in vitro. Proc. Natl. Acad. Sci. USA 79:7909-7913.
4. Cameron, J. M., I. McDougall, H. S. Marsden, V. G. Preston, D. M. Ryan, and J. H. Subak-Sharpe. 1988. Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target. J. Gen. Virol. 69:2607-2612.
5. Chatis, P. A., and C. S. Crumpacker. 1992. Resistance of herpesviruses to antiviral drugs. Antimicrob Agents Chemother. 36:1589-1595.
6. Coen, D. M. 1991. The implications of resistance to antiviral agents for herpesvirus drug targets and drug therapy. Antiviral Res 15:287-300.
7. Coen, D. M., D. J. Goldstein, and S. K. Weller. 1989. Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir. Antimicrob Agents Chemother. 33:1395-1399.
8. Cohen, E. A., J. Charron, J. Perret, and Y. Langelier. 1985. Herpes simplex virus ribonucleotide reductase induced in infected BHK-21/C13 cells: biochemical evidence for the existence of two non-identical subunit. H1 and H2. J. Gen Virol. 66:733-745.
9. Cohen, E. A., P. Gaudreau, P. Brazeau, and Y. Langelier. 1986. Specific inhibition of herpesvirus ribonucleotide reduclase by a nonapeptide derived from the carboxy terminus of subunit 2. Nature (London) 321:441-443.
10. Conner, J., F. Furlong, J. Murray, M. Meighan, A. Cross, H. Marsden, and J. B. Clements. 1993 Herpes simplex virus type 1 ribonucleotide reductase large subunit: regions of the protein essential for subunit interaction and dimerization. Biochemistry 32:13673-13680
11. Cormack, B. 1993 Mutagenesis by polymerase chain reaction, p. 8.5.7-8.5.9. In F. M. Ausubel, R. Brent, R E. Kingston, D. D. Moore, J. G. Seidman, J. A Smith, and K. Struhl (ed.). Current protocols in molecular biology, vol. 1. John Wiley and Sons Inc., New York.
12. Denizot, F., and R. Lang. 1986 Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89:271-277.
13. Dutia, B. M., M. C. Frame, J. H. Subak-Sharpe, W. N. Clark, and H. S. Marsden. 1986. Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides Nature (London) 321:439-441
14. Filatov, D., R. Ingemarson, A. Gräslund, and L. Thelander. 1992. The role of herpes simplex virus ribonucleotide reductase small subunit carboxyl terminus in subunit interaction and formation of iron-tyrosyl center structure. J. Biol. Chem. 267:15816-15822.
15. Goldstein, D. J., and S. Weller. 1988. Factor(s) present in herpes simplex virus type 1-infected cells can compensate for the loss of the large subunit of the viral ribonucleotide reductase, characterization of an ICP6 deletion mutant. Virology 166:41-51.
16. Graham, F. L., and A. J. van der Eb. 1973 A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:455-467.
17. Idowu, A. D., E. B. Fraser-Smith, K. L. Poffenberger, and R. C. Herman. 1992 Deletion of the herpes simplex virus type 1 ribonucleotide reductase gene alters virulence and latency in vivo. Antiviral Res. 17:145-156.
18. Ingemarson, R. 1989, Herpes simplex ribonucleotide reductase Dissertation. Umca University, Umca, Sweden.
19. Jacobson, J. G., D. A. Leib, D. J. Goldstein, C. L. Bogard, P. A. Schaffer, S. K. Weller, and D. M. Coen. 1989. A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive acute and reactivatable latent infections of mice and for replication in mouse cells. Virology 173:276-283.
20. Kibler, P. K., J. Duncan, B. D. Keith, T. Hupel, and J. R. Smiley. 1991. Regulation of herpes simplex virus true late gene expression: sequences downstream from the US11 TATA box inhibit expression from an unreplicated template. J. Virol. 65:6749-6760
21. Krogsrud, R. L., E. Welchner, E. Scouten, and M. Liuzzi. 1993. A solid-phase assay for the binding of peptidic subunit association inhibitors to the herpes simplex virus ribonucleotide reductase large subunit. Anal. Biochem. 213:386-394.
22. Langlois, M., J. P. Allard, F. Nugier, and M. Aymard. 1986. A rapid and automated colorimetric assay for evaluating the sensitivity of herpes simplex strains to antiviral drugs. J. Biol. Stand. 14:201-211.
23. Liuzzi, M. Personal communication.
24. Liuzzi, M., and R. Déziel. 1993 Inactivation of herpes simplex virus ribonucleotide reductase by subunit association inhibitors: a potential antiviral strategy, p 225-238. In J. Adams and V. J. Merluzzi (ed.), The search for antiviral drugs. Birkhauser, Boston.
25. Liuzzi, M., R. Déziel, N. Moss, P. Beaulieu, A. M. Bonneau, C. Bousquet, J. G. Chafouleas, M. Garneau, J. Jaramillo, R. L. Krogsrud, L. Lagacé, R. S. McCollum, S. Nawoot, and Y. Guindon. 1994. A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo. Nature (London) 372:695-698.
26. Liuzzi, M., E. Scouten, and R. Ingemarson. 1992. Inhibition of herpes simplex virus ribonucleotide reductase by synthetic nonapeptides: a potential antiviral therapy, p 129-138 In L. Walsh, T. M. Block, R Crowell, and D. L. Jungkind (ed.), Innovations in antiviral development and the detection of virus infections. Plenum Press, New York.
27. Liuzzi, M., and M. Talpaert-Borlé. 1988. Use of methoxyamine to quantify apurinic-apyrimidinic sites, p. 443-457. In E. C. Friedburg and P. C Hanawalt (ed), DNA repair, A laboratory- manual of research procedures, vol. 3, Marcel Dekker Inc., New York.
28. Mann, G. J., A. Gräslund, E.-I. Ochtai, R. Ingemarson, and L. Thelander. 1991. Purification and characterization of recombinant mouse and herpes simplex, virus ribonucleotide reductase R2 subunit Biochemistry 30:1939-1947.
29. McClements, W., G. Yamanaka, V. Garsky, H. Perry, S. Bacchetti, R. Colonno, and R. B. Stein. 1988. Oligopeptides inhibit the ribonucleotide reductase of herpes simplex virus by causing subunit separation. Virology 162:270-273.
30. McGeoch, D. J., M. A. Dalrymple, A. J. Davison, A. Dolan, M. C. Frame, D. McNab, L. J. Perry, J. E. Scott, and P. Taylor. 1988 The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1 J Gen Virol 69:1531-1574
31. Moss, N., P. Beaulieu, J.-S. Duceppe, J.-M. Ferland, J. Gauthier, E. Ghiro, S. Goulet, L. Grenier, M. Llinas-Bninet, R. Plante, D. Wernic, and R. Déziel. 1995. Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase, a new class of antiviral agents J. Med. Chem 38:3617-3623
32. Moss, N., R. Déziel, J. Adams, N. Aubry, M. Bailey, M. Baillet, P. Beaulieu, J. DiMaio, J. S. Duceppe, J. M. Ferland, J. Gauthier, E. Ghiro, S. Goulet, L. Grenier, P. Lavallée, C. Lépine-Frenette, R. Plante, S. Rakhit, F. Soucy, D. Wernic, and Y. Guindon. 1993. Inhibition of herpes simplex virus type 1 ribonucleotide reductase by substituted tetrapeptide derivatives. J. Med. Chem 36:3005-3009
33. Paradis, H., P. Gaudreau, P. Brazeau, and Y. Langelier. 1988. Mechanism of inhibition of herpes simplex virus (HSV) ribonucleotide reductase by a nonapeptide corresponding to the carboxyl terminus of its subunit 2. J. Biol. Chem. 263:16045-16050
34. Spector, T. 1993. 348U87 an inactivator of herpes virus ribonucleotide reductase that potentiates the antiviral activity of acyclovir. Drugs Future 18:25-28.
35. Uhlin, U., and H. Eklund. 1994. Structure of ribonuclotide reductase protein R1. Nature (London) 370:533-539.
36. Yamada, Y., H. Kimura, T. Morishima, T. Daikoku, K. Maeno, and Y. Nishjyama. 1991. The pathogenicity of ribonucleotide reductase-null mutants of herpes simplex virus type 1 in mice. J. Infect. Dis. 164:1091-1097